The association between demography, anthropometry, serum estrogen and breast density in patients having mammography in Hospital Universiti Sains Malaysia by Haron, Juhara
THE ASSOCIATION BETWEEN DEMOGRAPHY, 
ANTHROPOMETRY, SERUM ESTROGEN AND 
BREAST DENSITY IN PATIENTS HAVING 
MAMMOGRAPHY IN HOSPITAL UNIVERSITI 
SAINS MALAYSIA 
By 
DR. JUHARA BTE HARON 
Dissertation Submitted In Partial 
Fulfillment Of The Requirements For 
The Degree Of Master Of Medicine 
(Radiology) 
UNIVItRSJTl SAINS MALAYSIA 
UNIVERSITI SAINS MALAYSIA 
2006 
To 
My beloved husband 
A strong determinant person 
His loves, patience, understanding and moral support enables me to 
complete this project and my master program. 
My two lovely sons 
Muhamad Afif and Muhamad Iman 
Their cheers and smiles relief my stress 
Their understanding make all this possible 
My in-laws 
Thanks for their full moral support 
They enlighten my day and my daily duties 
My mother 
Her loves and constant moral support make me 
a better and stronger person 
11 
ACKNOWLEDGEMENTS 
Alhamdulillah, with the help of Allah Subhanahuwataala, the author was able to complete 
this dissertation project according to the schedule. The author would like to express her 
deepest gratitude and thanks to many people who were direct or indirectly contributed to 
the preparation and completion this project and manuscript: 
• My supervisor, Dr Latifah Mohd Basheer, Lecturer of Radiology Department, 
Hospital Universiti Sains Malaysia. Thank you very much for her guidance, 
patience and great knowledge on the research field. 
• My co-supervisor, Dr Nik Hazlina Nik Hussain, Lecturer of Obstetric and 
Gynaecology Department, Pusat Pengajian Sains Perubatan, Universiti Sains 
Malaysia. Her enthusiasm on research had inspires the author and give courage to 
complete the project. Without her contribution, this project might not be possible. 
• My co-supervisor, Dr Nik Munirah Nik Mahdi, Lecturer of Radiology 
Department, Hospital Universiti Sains Malaysia. Her assistance in the final draft 
enabled me to submit the project according to schedule. 
• Dr Kamarul Imran Musa, Lecturer in Department of Community Medicine, Pusat 
Pengajian Sains Perubatan, Universiti Sains Malaysia. His biostatistics expertise 
enabled this project to be analyzed and submitted. 
• Universiti Sains Malaysia for funding this work under short-term grant. 
111 
• All the lecturers in Radiology Department, Hospital University Sains Malaysia. 
Thank you for their guidance, comments, critical suggestions and concern starting 
from the beginning of the project until the project was completed. 
• SIN Roslaini and SIN Nor Aeni for their help. Thank you also for the other staff 
nurses who indirectly involved in this project. 
• Mammography Radiographer, Kak Rohani and Siti Salwa. 
• Puan In tan I diana, Research Officer of Kacip Fatimah Study. 
• Staff nurses in Obstetric and Gynecology Department, Universiti Sains Malaysia 
for their contribution. 
• My friends and colleagues, thanks for their moral support. They were there to 
share the cheers and tears along the master program and until completion of the 
dissertation. 
• All staffs in Radiology Department. 
IV 
CONTENTS 
ACKNOWLEDGEMENTS ............................................................................................ iii 
CONTENTS ....................................................................................................................... v 
LIST OF TABLES ......................................................................................................... viii 
LIST OF FIGURES ......................................................................................................... ix 
ABBREVIATIONS .......................................................................................................... xi 
ABBREVIATIONS .......................................................................................................... xi 
ABSTRAK ....................................................................................................................... xii 
ABSTRACT .................................................................................................................... xiv 
I INTRODUCTION ...................................................................................................... I 
I.I Epidemiology ...................................................................................................... 1 
I.2 Breast density and breast cancer ......................................................................... 2 
I.3 Breast Awareness Program ................................................................................. 4 
1.4 Breast cancer risks .............................................................................................. 5 
2 LITERATURE REVIEW ........................................................................................... 9 
2.I Anatomy of the breast ......................................................................................... 9 
2.l.I Surface anatomy of the female breast. ...................................................... I 0 
2.I.2 Blood supply ............................................................................................. II 
2.1.3 Lymphatic drainage .................................................................................. 11 
2.1.4 Nervous supply ......................................................................................... I2 
2.2 Physiological changes of the breast .................................................................. I2 
2.2.I Breast changes during pregnancy ............................................................. I4 
2.2.2 Breast changes after menopause ............................................................... I4 
2.3 Physiology of reproductive hormones .............................................................. I4 
2.3 .I Menstrual cycle ......................................................................................... I5 
2.3.2 Hormones of the menstruation .................................................................. 15 
2.3 .3 The endocrine and physiology of menstrual cycle ................................... 15 
2.4 Breast density assessment ................................................................................. 17 
v 
2.4.1 Wolfe classification .................................................................................. 18 
2.4.2 Laszlo Tabar classification ....................................................................... 19 
2.4.3 BIRADS classification .............................................................................. 20 
2.4.4 Boyd classification .................................................................................... 22 
2.4.5 Computer-aided quantitative assessment. ................................................. 23 
2.5 Imaging of breast .............................................................................................. 23 
2.5.1 Mammography .......................................................................................... 23 
2.5.2 Breast Ultrasound ...................................................................................... 28 
2.5.3 MRI breast ................................................................................................ 31 
2.6 Breast pathology ............................................................................................... 33 
2.6.1 Benign breast lesion .................................................................................. 33 
2.6.2 Malignant breast lesion ............................................................................. 33 
3 AIMS AND OBJECTIVES ...................................................................................... 34 
3.1 Aim ................................................................................................................... 34 
3.2 Objectives ......................................................................................................... 34 
3.2.1 General ...................................................................................................... 34 
3.2.2 Specific ..................................................................................................... 34 
4 METHODOLOGY ................................................................................................... 35 
4.1 Study design ...................................................................................................... 35 
4.2 Population and Sample ..................................................................................... 35 
4.2.1 Reference population ................................................................................ 35 
4.2.2 Source population ..................................................................................... 35 
4.2.3 Sampling frame ......................................................................................... 35 
4.2.4 Sample size calculation ............................................................................. 36 
4.2.5 Sampling method ...................................................................................... 36 
4.3 Research tools ................................................................................................... 37 
4.4 Data collection .................................................................................................. 38 
4.4.1 Variables ................................................................................................... 38 
4.4.2 Definitions ................................................................................................. 38 
4.5 Statistical analysis ............................................................................................. 40 
4.5.1 Analysis ..................................................................................................... 40 
4.5.2 Software .................................................................................................... 41 
4.6 Ethical consideration ........ ~ ................................................................................ 41 
5 RESULTS ................................................................................................................. 42 
Vl 
6 DISCUSSION ........................................................................................................... 66 
6.1 Breast density and demography ........................................................................ 66 
6.1.1 Breast density and parity ........................................................................... 67 
6.1.2 Breast density and other demographic variables ...................................... 69 
6.2 Breast density and anthropometry .................................................................... 69 
6.3 Breast density and serum estrogen .................................................................... 72 
7 SUMMARY AND CONCLUSION ......................................................................... 74 
8 PROBLEMS AND LIMITATIONS ......................................................................... 75 
9 RECOMMENDATIONS .......................................................................................... 76 
I 0 REFERENCES ..................................................................................................... 77 
11 APPENDIX ........................................................................................................... 83 
vii 
LIST OF TABLES 
Table 5-1 Characteristics of patients with mammography in Hospital Universiti 
Sains Malaysia ................................................................................................................. 43 
Table 5-2 Distribution of variables between dense and non-dense group of breast 
density' .............................................................................................................................. 44 
Table 5-3 Prevalence of different characteristics of patients with mammography in 
Hospital Universiti Sains Malaysia .......•...•.............••.............••..•.•..............••..•..••••..••.•.. 45 
Table 5-4 Distribution of body mass index between dense and non-dense group of 
breast density' .......•.•....••....•..........•....••.•.•....•..............•..•..................••.............................. 55 
Table 5-5 Distribution of waist hip ratio between dense and non-dense group of 
breast density' •.•...••.•...•.....•.....••.......•.......•............••........•••••..•...•.....•.••............................. 57 
Table 5-6 Distribution of estrogen level between dense and non-dense group of 
breast density' ................................................................................................................... 59 
Table 5-7 Distribution of parity' between dense and non-dense group of breast 
density .............................................................................................................................. 61 
Table 5-8 Univariable analysis using simple binary logistic regression of the 
association between independent variables and breast density' .................................. 62 
Table 5-9 Final model of the association between various independent variables 
with breast density' using multivariable binary logistic regression ............................ 64 
viii 
LIST OF FIGURES 
Figure 2-1 Breast ducts, lobules and terminal acini ...................................................... 9 
Figure 2-2 Surface anatomy of the breast ......................................................•.............. 10 
Figure 2-3 Lymphatic drainage of the breast .....•............••....•...........•.••....................... 12 
Figure 2-4 Approximate concentrations of pituitary and ovarian hormones during 
menstrual cycle ........................................................•......................................................• 16 
Figure 2-5 Fatty breast ....................•.............................................................................. 20 
Figure 2-6 Scattered fibro glandular density ............................................................... 21 
Figure 2-7 Heterogeneously dense .........•••..•.............•.•.••...•...........•.....•...•................••..• 21 
Figure 2-8 Extremely dense ...•......•.............•....••..................•.••••..................................... 22 
Figure 2-9 Standard cranio-caudal (CC) view ............................................................. 25 
Figure 2-10 Standard mediolateral oblique (MLO) view ............................................ 26 
Figure 2-11 Radiographic density within breast mammogram ....•.........•.......•........... 27 
Figure 2-12 Benign cystic lesion .........•........••••...........•.•.•.....•..••••.•••..............••...•.••....••.. 29 
Figure 2-13 Malignant cystic lesion .....••..........•...........•...............•..............••................. 29 
Figure 2-14 Benign solid breast lesion ...•.....•••.........................•.••.•.....•.•.••••••................ 30 
Figure 2-15 Malignant solid breast lesion ..................................................................... 30 
Figure 2-16 Normal MRI breast in T1 weighted ......................................................... 31 
Figure 2-17 Normal MRI breast in T2 weighted ......................................................... 32 
Figure 2-18 Normal MRI breast post IV contrast (Gadolinium) ............................... 32 
Figure 5-1 Distribution of age of patients .........•...•.••..•.•.•••••••••••••••...................•••.••..... 46 
Figure 5-2 Distribution of age at menarche •••••............•...........•.............•...........•....•.... 47 
IX 
Figure 5-3 Distribution of age at menopause .............................................................. 48 
Figure 5-4 Distribution of duration of menopause ...................................................... 49 
Figure 5-5 Distribution of duration of menstruation .................................................. 50 
Figure 5-6 Distribution of duration since last child birth in years ........•.................... 52 
Figure 5-7 Distribution of body mass index (kg/m2) ................................................... 54 
Figure 5-8 Frequency and proportion of subjects according to group of body mass 
index ................................................................................................................................. 55 
Figure 5-9 Distribution of waist hip ratio .................................................................... 56 
Figure 5-10 Frequency and proportion of subjects according to waist hip ratio ..•.•. 57 
Figure 5-11 Distribution of serum estrogen •.........................••••..•..........•..................•.. 58 
Figure 5-12 Frequency and proportion of subjects according to group of breast 
density .............................................................................................................................. 53 
X 
ABBREVIATIONS 
ANCOVA Analysis of covariance 
BIRADS Breast Imaging And Data System 
BMI Body mass index 
cc Cranio-caudal 
HUSM Hospital Universiti Sains Malaysia 
HRT Hormone Replacement Therapy 
MLO Mediolateral oblique 
MRI Magnetic Resonance Imaging 
SPSS Statistical Software for Social Sciences 
WHR Waist hip ratio 
XI 
ABSTRAK 
Topik: Perkaitan Antara Demografi, Antropometri, Serum Estrogen dan Ketebalan Tisu 
Payudara Di Kalangan Pesakit Yang Membuat Pemeriksaan Mamografi di Hospital 
Universiti Sains Malaysia. 
Latarbelakang: Kanser payudara merupakan kanser yang biasa di kalangan wanita. 
Mengikut laporan dari Malaysia National Cancer Registry 2002, kanser payudara 
menyumbangkan lebih kurang 30.4% dari keseluruhan kes-kes kanser diikuti oleh kanser 
serviks (12.4%). Banyak faktor telah dikenalpasti sebagai penyumbang kepada 
peningkatan risiko kanser payudara ini. Salah satu daripadanya ialah ketebalan tisu 
payudara. Tisu payudara yang tebal dalam pemeriksaan mamografi juga dikatakan 
berkaitan dengan proliferasi epitelium and parut stroma. Kaitan antara jenis histologi tisu 
payudara dan risiko kanser boleh diterangkan melalui tindakan faktor pertumbuhan 
(hormon) yang memainkan peranan dalam perkembangan fisiologi payudara dan proses 
pertumbuhan kanser. Risiko ini juga mungkin disebabkan tisu payudara yang tebal 
menghalang kanser daripada mudah dikesan. Faktor-faktor lain seperti wanita yang tidak 
pemah mengandung (nulipariti), mengandung sulung pada lewat umur, umur lebih muda, 
bilangan anak, umur dan jangkamasa putus haid, indeks jisim badan, pengambilan 
hormon gantian dan serum estrogen berkemungkinan menyebabkan risiko kanser 
payudara melalui kesan tidak langsung terhadap ketebalan tisu payudara. Oleh itu kajian 
ini bertujuan mengkaji sama ada wujud perkaitan antara faktor demografi, antropometri, 
serum estrogen dan ketebalan tisu payudara. 
xii 
Metodologi dan Bahan: Ini merupakan kajian keratan lintang selama 1 tahun bermula 
dari bulan Mei 2004 sehingga Mei 2005. Data diambil dari pesakit yang datang untuk 
melakukan pemeriksaan mamografi di Jabatan Radiologi, Universiti Sains Malaysia 
(HUSM), Kubang Kerian, Kelantan di dalam tempoh tersebut. Data daripada 84 orang 
pesakit berj aya dikumpulkan. 
Keputusan: Terdapat perkaitan yang ketara antara indeks jisim badan (p=0.033), 
bilangan anak (p=0.002) dengan ketebalan tisu payudara. Indeks jisim badan mempunyai 
perkaitan songsang dengan ketebalan tisu payudara. Keputusan menunjukkan bahawa 
pesakit yang mempunyai indeks jisim badan yang tinggi mempunyai kebarangkalian 
lebih rendah untuk berkait dengan tisu payudara yang tebal. Setiap satu unit kenaikan 
indeks jisim badan, kebarangkalian untuk berkait dengan tisu payudara yang tebal adalah 
0.86 kali. Bilangan kelahiran juga berkadar songsang dengan ketebalan tisu payudara. 
Bagi setiap pertambahan bilangan kelahiran, kemungkinan untuk mempunyai tisu 
payudara yang tebal menurun sebanyak 31% (95% CI, penurunan risiko dari 12% hingga 
46% ). Serum estrogen walau bagaimanapun bukan merupakan variabel tersendiri yang 
ketara terhadap tisu payudara. 
Kesimpulan: Indeks jisim badan dan bilangan anak tetapi tidak serum estrogen 
mempunyai perkaitan ketara dengan ketebalan tisu payudara setelah mengambil kira 
faktor luaran yang boleh mempengaruhinya. 
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ABSTRACT 
Topic: The Association between Demography, Anthropometry, Serum Estrogen and 
Breast Density in Patients Having Mammography in Hospital Universiti Sains Malaysia 
Background: Breast cancer is the most common cancer in female. Report from 
Malaysia National Cancer Registry (NCR) 2002 showed that breast cancer account for 
30.4% of all cancers followed by cervical cancer (12.4%). Many contributing factors 
have been identified to increase the risk of developing breast cancer. One of the factors is 
breast density. Dense breast tissue by mammography is associated both with epithelial 
proliferation and with stromal fibrosis. The relationship between these histological 
features and risk of breast cancer may be explained by the known actions of growth 
factors (hormones) that are thought to play important roles in breast development and 
carcinogenesis. The risk might be partly due to masking of tumors by dense tissue. Other 
factors such as nulliparity, late age at first birth, younger age, parity, age and duration of 
menopause, body mass index, hormone replacement therapy and serum estrogen may 
potentially affect breast cancer risk through their indirect effect on breast density. The 
aims of the study were to determine the characteristics of patients with mammography in 
Hospital Universiti Sains Malaysia and to determine the independent variables associated 
with breast density. 
Methods and Materials: This study was a cross-sectional study conducted for one year 
duration from May 2004 to May 2005. Data were taken from patients who came for 
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mammography in Radiology Department, Hospital Universiti Sains Malaysia (HUSM), 
Kubang Kerian, Kelantan during the study period. Data from 84 patients were collected. 
Results: Significant association noted between body mass index (p=0.033), parity 
(p=0.002) and breast density. Body mass index showed inverse relationship with breast 
density meaning that patients with higher body mass index had lower chance of being 
associated with dense breast. Results showed that for every one unit increase in body 
mass index, there is 0.86 times chance of association with dense breast. Inverse 
relationship also noted between parity and breast density. One unit increased in parity 
was associated with 31% reduction in chances of having dense breast (95% Cl, risk 
reduction range from 12% to 46% ). Serum estrogen however was not a significant 
independent variable for breast density. 
Conclusion: Body mass index and parity but not serum estrogens were significantly 
associated with breast parenchyma when adjusted for potential confounding factors. 
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1 INTRODUCTION 
1.1 Epidemiology 
It is depressing to see the current global health trend as the incidence of cancer 
among population is on the rise. Many factors have been identified as contributing 
factors to these phenomena. These could be due to our environment and lifestyle. 
Based on the report from the Malaysia National Cancer Registry (NCR) 2002, the 
cumulative risk of cancer in Peninsular Malaysia was 18% meaning that I in 5.5 
Malaysians can be expected to get cancer in their lifetime. Taking into account 
cancer cases which were not registered by the NCR, the risk could be higher with 
probably I in 4 Malaysians getting cancer in their lifetime (Ministry of Health 
Malaysia 2002). It was also reported that the incidence is higher in Chinese and 
Indians compared to Malays. The different in racial incidence is most likely due to 
contributing risk factors such as lifestyle. The Chinese have a higher status of 
socioeconomic, more likely to have less children, have their children later in life and 
less likely to breast feed their children than Malays. Other factors could be due to 
dietary intake and genetic predisposition among races. However, there is lack of data 
on genetic predisposition among races in Malaysia (Har 2005). 
Second Report from the Malaysia National Cancer Registry (NCR) 2003 
reported crude rate of cancer incidence for males was 97.4 per 100,000 population 
and 127.6 per 100,000 populations for female. Median age at diagnosis for males was 
59 and for females were rather younger, 53. The common cancers among females 
were breast, cervix, ovary, uterus, thyroid gland and leukemia. Among females, the 
most frequent cancer was cancer of the breast (31.0% of all female cancer) which is 
significantly higher than the second most common cancer that is cervical cancer 
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(12.9%). In regards to female breast cancer, in 2003 there were 3738 cases reported 
accounted for 31.0% of newly diagnosed female cases. It was the commonest cancer 
in all ethnic groups and all age groups from the age of 15. Peak age incidence was 
50-59 and 64.1% were women between 40 and 60 years of age (Ministry of Health 
Malaysia 2003). 
In view of the above mentioned scenario, we can make a conclusion that in 
overall, cancer (breast cancer especially) is a serious health problem without 
overlooking on other major health problems such as cardiovascular disease, diabetes 
mellitus, hypertension etc. 
1.2 Breast density and breast cancer 
Breast density is an important contributing factor for breast cancer and the 
influence of breast density on the risk of developing breast cancer has been discussed 
in many studies and published in many articles. Many studies have been done to look 
for association between breast density and risk factors for breast cancer. Few studies 
emphasized on factors affecting breast density such as body mass index, smoking, 
nulliparity, hormone replacement therapy, age at menarche, menopausal status, race, 
diet and family history of breast cancer. 
A large study was conducted to assess the role of the Wolfe classification of 
breast parenchyma pattern as a breast cancer risk together with a set of well-
established risk factors for breast cancer. The study showed that there was an 
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association between parenchyma pattern and the risk of breast cancer (Carlile, 
J .Kopecky et al. 1985). 
Study done by Van Gils on relationship between parity and breast cancer risk 
showed 7. I increased risk of breast cancer in nulliparous women with breast density 
of ~5%. The result of the study suggested that high breast density (reflecting fibro-
glandular tissue with increased epithelial cell proliferation) was more susceptible to 
carcinogenic effects (Van Gils 1999). 
Recent epidemiological studies have reported more than four-fold higher risk of 
breast cancer for higher breast density. This is biologically explained as breast 
cancers arising from the epithet ial lining of the ductal glandular structures (Van Gils 
1999). Egan and Mosteller hypothesized that the association between breast density 
and subsequent risk of cancer might be due to "masking" of tumour by dense tissue 
(Benichou, Byrne et al. 2003). This could be due to reduction in sensitivity of 
mammogram in dense breast. 
Study also has been done to look for association between age, menopausal 
status and breast cancer risk. Byrne et al. found a greater effect of breast density on 
risk of breast cancer in post menopausal women compared to pre menopausal women. 
Another study by Boyd et al. also found higher risk for women age 50-59 compared 
with women age 40-49. However, because of small sample size, these two studies did 
not show strong relationship between increased breast density and cancer risk 
according to menopausal status (Harvey and Bovbjerg 2004). 
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Understanding the physiological changes of breast parenchyma throughout life 
is crucial in order to know the confounding factors affecting breast density. It is well 
explained by many literatures that the density of breast tissue is influenced by the 
hormonal status particularly the estrogen level. Physiological changes of breast 
parenchyma have been discussed in detail in the Literature Review (Section 2). 
However, it is still a controversial issue whether breast density is an independent risk 
factor or plays a role as a marker for breast cancer. 
1.3 Breast Awareness Program 
There are many campaigns and programs launched by the Ministry of Health 
Malaysia to either reduce the incidence of major health problems in general or cancers 
especially breast cancer. One of the programs is breast screening program in which it 
encourages women at the age of 40 and above to have their breast screened for 
malignancy. Self breast examination has also been promoted as a method to detect 
any breast abnormality. 
Guidelines for mammography for Breast Screening in Malaysia have been 
outlined by the General Practice Guideline. The guidelines include high risk women 
with past history of breast and or ovarian cancer, family history of breast cancer in 
one or more first or second degree relatives before the age of 50 years and history of 
cellular atypia on previous biopsy before the age of 40 years and asymptomatic 
women. Mammography should be done annually for women age 40-49 years and 
annually or biennially for women age 50-75 years old (Ministry of Health 2002). 
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Mammography is the best method to screen for any breast lesions. However, 
there is 20% false negative rate of mammography. Therefore, correlation between 
mammography and clinical findings are very important. A recent report from 
National Evaluation Team for Breast Cancer Screening (NETB) indicated cancer 
detection rates of 4.5-10 per 1,000 for prevalence screens and 3.0-4.8 for incidence 
screens. The positive predictive value of an abnormal mammogram was 50-60%. 
1.4 Breast cancer risks 
Several factors have been identified as potentially responsible for increasing breast 
cancer risk. These factors are:-
i) Previous history of breast cancer. 
ii) Increasing age. 
iii) Geographic variation. 
iv) Family history. 
v) Biopsy confirmed benign proliferative breast disease 
i) Previous radiation to the breast. 
ii) Nulliparity (women who never been pregnant) at 40 years of age. 
iii) First full term pregnancy at age of35 or more. 
iv) Early menarche (aged 12 and younger). 
v) Late menopause (age 55 and older). 
vi) History of primary cancer of the ovary or endometrial. 
vii) Obesity in postmenopausal women. 
viii) Evidence of specific genetic susceptibility (such as carriage of BRCA 1, 
BRCA@ or BRCA3). 
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ix) Staple diet containing red meat, high total fat (especially saturated fat) and 
alcohol. 
x) Hormone replacement therapy- the Women Health Initiative study found 
an increased risk of breast cancer (Hazard Ratio 1.26) in women on 
hormone replacement therapy with combined estrogen plus progestin 
given in a continuous manner. 
The above mentioned factors are directly contributing to the risk of breast 
cancer through direct pathological influence. As there are many potential causes 
contributing to breast cancer, many studies and effort have been put up to either 
reduce the risk of breast cancer or detect the problem early. Many studies have been 
done to look for association between the risk factors and occurrence of breast cancer. 
Based on these studies, many theories and hypothesis have been postulated and 
published and opened for discussion. 
Women with previous history of breast cancer have 5-fold increased risk of 
breast cancer in the contra-lateral breast. The risk is about 1% per year of survival and 
increased in the presence of other associated risk factors such as hereditary breast 
cancer and proliferative changes in the remaining breast (Sakorafas 2002). 
Prospective cohort study for 18 years in 6689 women participating in the 
Copenhagen City heart study concluded that high endogenous concentrations of 
estrogen are a known risk factor for breast cancer and impairment of estrogen 
synthesis induced by chronic stress may explain a lower incidence of breast cancer in 
women with high stress. However, this is not considered a healthy response, and the 
6 
cumulative health consequences of stress may be disadvantageous (Nielsen, Zhang et 
al. 2005). 
Obesity is a known factor for breast cancer. Harvey and Bovberg 2004 in their 
article wrote that Lam et al. examined the relationship between the weight and body 
mass index on the association of breast density and breast cancer risk. It was found 
that women with higher body weight and body mass index were less likely to have 
dense breast. However, after adjusted for weight and body mass index, the odd ratio 
was increased to 4.5. The study concluded that the confounding of these two factors 
on breast cancer risk tends to be underestimated when not adjusted for body mass 
index (Harvey and Bovbjerg 2004). 
Mutation in BRCA gene is a known genetic susceptibility factor for breast 
cancer. The risk is different between the non-Ashkenazi Jewish or Ashkenazi Jewish. 
For non-Ashkenazi Jewish those at risk are, any 2 first-degree relatives with breast 
cancer, 1 of whom received the diagnosis at the age of 50 years or younger; a 
combination of 3 or more first-degree or second-degree relatives with breast cancer 
regardless of age at diagnosis; a combination of both breast and ovarian cancer among 
first-degree and second-degree relatives; a first-degree relative with bilateral breast 
cancer; a combination of 2 or more first-degree or second-degree relatives with 
ovarian cancer regardless of age at diagnosis; a first-degree or second-degree relative 
with both breast and ovarian cancer at any age; and a history of breast cancer in a 
male relative. For women of Ashkenazi Jewish heritage, an increased-risk family 
history includes any first-degree relative (or 2 second-degree relatives on the same 
side of the family) with breast or ovarian cancer (U.S Preventive Task Force 2005). 
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Study on mutation spectrum of BRCA 1 gene done on 49 Malay breast cancer patients 
in Singapore strongly suggest that the 2845insA mutation, the most common 
deleterious mutation in the study may possibly a founder mutation in breast cancer 
patients of Malay ethnic background (Lee, Ho et al. 2003). 
Knowing the above mentioned facts, this study was designed to look for any 
association between the risk factors for breast cancer such as estrogen level, 
demographic characteristic, anthropometric measurement and breast density. 
Consideration was also given for other factors such as age, menstrual history, 
menopausal status, body mass index, waist hip ratio and reproductive factors such as 
parity. This study was designed to look for any significant association between the 
above factors and to discuss on the possible explanation regarding association. As 
most of the studies were done by the Western Countries, probably the author would 
like to know the data for the Malaysian population or specifically for the patient who 
came for mammography in Hospital Universiti Sains Malaysia. Many studies have 
been done by the Western countries on factors associated with breast density but no 
similar study has been done locally. Results from this study might be useful 1n 
preventive management of breast cancer in Malaysia. 
8 
F) ,....1 \/j ~ \\ / .J~~ J ~~ JJ 
2 LITERATURE REVIEW 
2.1 Anatomy of the breast 
AC.,NI 
Figure 2-1 Breast ducts, lobules and terminal acini 
(G. Grainger and Allison 1999) 
The breast contains 15-20 lobes. Each lobe comprises a variable number of 
lobules, which consist of 10-100 acini or blind-ending sacs (Figure 2-1) (G.Grainger 
and Allison 1999). Fifteen to twenty lobes disposed radially around nipple and each 
lobe has a main lactiferous duct of 2.0-4.5mm converging at the nipple with an 
opening in the central portion ofthe nipple (Dahnert 1996). 
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The breast ducts form a branching structure that conveys milk from the acini 
to the nipple. The various sized ducts can be described on the basis of their location as 
intralobular, interlobular, intralobar and interlobar (G.Grainger and Allison 1999). 
2.1.1 Surface anatomy of the female breast 
The adult female breast lies vertically from the 2"d to the 6th rib and in the transverse 
plane from the lateral border of the sternum to the mid-axillary line. 
Adipose Cells 
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Figure 2-2 Surface anatomy of the breast 
(G.Grainger and Allison 1999) 
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Breast is made up of essentially three distinct components. Glandular and 
ductal tissue constitutes the parenchyma. These tissues are the most important 
component and they are arranged in lobes. Between the glandular tissues run fibrous 
and fatty tissues. No distinct capsules seen but the subcutaneous tissue which envelop 
the gland send septa into it to act as a supporting framework for the various lobules. 
The fibrous tissue at it most developed upper part of the breast is known as 
suspensory ligaments (Tucker and Ng 2001 ). 
2.1.2 Blood supply 
The arterial supply to the breast is from the lateral mammary branch of the 
lateral thoracic artery, the anterior cutaneous perforating branch of the internal 
mammary artery and branches are also derived from the 2"d to the fifth intercostals 
arteries. 
The veins describe an anastomotic circle around the base of the nipple, so 
called the circulus venosus which then drains into axillary and internal mammary 
veins (Tucker and Ng 2001). 
2.1.3 Lymphatic drainage 
It is divided into superficial and deep plexus of lymphatic vessels. The 
superficial plexus lies beneath the skin superficial to the gland. The deep plexus lies 
in deep fascia of which the mammary gland rests. The lymphatic drainage is as 
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illustrate in the diagram. This lymphatic drainage is very important in understanding 
the spread of malignant disease (Tucker and Ng 2001). 
Axillary Nodes/ 
Parasternal Nodes 
/ 
Figure 2 .. 3 Lymphatic drainage of the breast 
Adapted from the Internet (Anonymous) 
2.1.4 Nervous supply 
Breast is supplied by the lateral and anterior cutaneous branch from the 4th, 5th 
and 6th intercostals nerves (Tucker and Ng 2001 ). 
2.2 Physiological changes of the breast 
Female breasts do not begin growing until puberty that is the period in life when 
the body undergoes a variety of changes to prepare for reproduction. Puberty usually 
begins for women around age 10 or II. After pubic hair begins to grow, the breasts 
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will begin responding to hormonal changes in the body. Specifically, the production 
of two hormones, estrogen and progesterone, signal the development of the glandular 
breast tissue. 
The size and shape of women's breasts varies considerably. Some women have 
a large amount of breast tissue, and therefore, have large breasts. Other women have a 
smaller amount of tissue with little breast fat. 
Factors that may influence a woman's breast size include volume of breast 
tissue, family history, age, weight loss or gain, history of pregnancies and lactation, 
thickness and elasticity of the breast skin, degree of hormonal influences on the breast 
(particularly estrogen and progesterone) and menopause. 
Breast shape and appearance undergo a number of changes as a woman ages. In 
young women, the breast skin stretches and expands as the breasts grow, creating a 
rounded appearance. Young women tend to have denser breasts (more glandular 
tissue) than older women. 
The mature breast undergoes cyclic changes during the menstrual cycle. 
Estrogen increases cell proliferation and progesterone enhances this effect. During the 
follicular phase, cell proliferation increases and is further enhanced during the luteal 
phase. During each menstrual cycle, breast tissue tends to swell from changes in the 
body's levels of estrogen and progesterone. The milk glands and ducts enlarge, and in 
tum, the breasts retain water. During menstruation, breasts may temporarily feel 
swollen, painful, tender, or lumpy. 
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2.2.1 Breast changes during pregnancy 
During pregnancy, a variety of breast changes occur. Typically, breasts 
become tender and the nipples become sore a few weeks after conception. The breasts 
also increase in size very quickly. It is not uncommon for a woman's breasts to 
increase by one or two cup sizes during and after pregnancy. The most rapid period of 
breast growth is during the first eight weeks of pregnancy. The Montgomery's gland 
surrounding the areola (pigmented region surrounding the nipple) becomes darker and 
more prominent, and the areola itself darkens. The nipples also become larger and 
more erect as they prepare for milk production. The blood vessels within the breast 
enlarge as surges of estrogen stimulate the growth of the ducts and surges of 
progesterone cause the glandular tissue to expand. 
2.2.2 Breast changes after menopause 
After the menopause, the mammary gland tissues atrophies or involutes. 
Ovarian hormones are no longer stimulated and the secretory cells of the alveoli 
degenerate. Some of the ductal tissues remain and the connective tissue components 
are also degenerate. 
2.3 Physiology of reproductive hormones 
Understanding the physiology of the reproductive system is useful in 
determining the hormonal level and reproductive status of women. Women who are 
still menstruating are considered to be fertile. This fertile period starts at menarche 
and ends with the menopause 
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2.3.1 Menstrual cycle 
Menstrual cycle starts at the first day of menses and ends at the day preceding 
the next menstruation. This period is divided in cycle of 28 to 35 days in length 
separated by menstruation. 
2.3.2 Hormones of the menstruation 
The regulation of hormones is through the hypothalamic-pituitary axis. 
Gonadotrophin Releasing Hormone (GnRH) controls the release and synthesis of 
Follicle Stimulating Hormone (FSH) and Luteinising Hormone (LH). 
The action of FSH is to allow recruitment and growth of the ovarian follicles 
while LH induces follicular rupture and sustain the corpus luteum. Estradiol ts 
produced by the follicles and Progesterone by the corpus luteum (Bischof2003). 
2.3.3 The endocrine and physiology of menstrual cycle 
The interplay between pituitary and ovarian hormones gives rise to a 
stereotyped pattern of hormone level during the menstrual cycle. The graph below 
shows relative hormone levels in an average 28-day cycle. 
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Figure 2-4 Approximate concentrations of pituitary and ovarian 
hormones during menstrual cycle 
Adapted from Internet (Anonymous) 
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Figure 2-4 represent the variation in serum estradiol level during menstruation. 
The serum estradiol started to surge after the starting of menstruation and continues to 
increase during the Follicular Phase until the starting of ovulation. After the ovulation 
that is during the Luteal Phase, there is period when the estradiol level is at the stable 
level. This is at about day 16 to 24 of menstrual cycle. 
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2.4 Breast density assessment 
There are many ways to assess the mammography density of the breast 
parenchyma. More accurate assessment of breast density is by measuring the amount 
of breast tissue by digital mammography using the available software. Another 
method of assessing the breast density is by qualitative assessment through breast 
parenchyma pattern. Even though qualitative assessment of breast density is not as 
accurate as computer-aided measurement, crudely we are able to use the parenchyma 
pattern to categorize the breast into the dense and the non-dense type of breast tissue. 
Breast parenchyma pattern as describe in Literature Review (page 18-23) is a method 
of describing the amount of fat and glandular tissue in the breast. Dense breast will 
have more amount of glandular tissue compared to the non-dense breast which has 
more amount of fat. 
Study by Van Gils et al measured the breast density by measuring the breast 
tissue from a digitized mammogram. The study categorized into the breast density 
into < 5%, 5-25% or > 25% density (Van Gils 1999). Semi-quantitative assessment of 
breast density by Boyd classification scale was used in study on breast density and 
breast cancer risk factors in a high risk population (Warwick, Pinney et al. 2003). 
Four categories of breast parenchyma as described by Wolf was Nl, PI, P2 and DY 
(refer to page 18-23 on Literature Review). BIRADS also described four categories of 
breast parenchyma similar to Wolfe (Vacek and Geller 2004). Another study 
categorized breast parenchyma density into less than 25%, 25-49.99o/o, 50-69.99% 
and 70-99.99%. The <25% and 25-49.99% groups were grouped into corresponding 
N 1 and PI pattern which is taken as reference category and the rest two groups were 
put into corresponding P2 and DY pattern as described by Wolfe which is taken as 
high risk group for breast cancer (Wolfe, Saftlas et al. 1987). In our study, BIRADS 
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classification of breast parenchyma pattern was used as reference of mammography 
parenchyma breast densities as it is readily used by the Radiologists in our department 
in assessing large number of mammograms. 
The classification of breast parenchyma patterns is based on relative amount of 
radiographic densities that corresponds to connective and epithelial tissues within the 
breast (Wolfe, Saftlas et al. 1987). There are many mammographic classification of 
the breast parenchyma pattern which represents the breast density. The density of the 
breast parenchyma can be assessed qualitatively or quantitatively. Qualitatively the 
breast parenchyma is classified using Wolfe, Laszlo Tabar and BIRADS (American 
College of Radiology Breast Imaging and Data System) methods. Semi quantitative 
assessment was done by Boyd et al. and quantitative measurement was made by 
computed-aided calculation of fibre-glandular area from digitized mammograms. 
(Chow, Venson et al. 2000) 
2.4.1 Wolfe classification 
Wolfe method described four parenchyma patterns based on the relative amount of 
fat, epithelial and connective tissue density 
N I : normal. The breast parenchyma is of low density and has a large proportion of 
fat. No ducts are visible. 
PI: the parenchyma is composed mainly of fat, with a prominent duct pattern in the 
anterior portion of the breast but involving less than one quarter of the breast volume. 
P2: prominent duct pattern which involves more than one-quarter of the breast 
volume and often associated with nodular component. 
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DY: increased density of the breast parenchyma with or without areas of nodularity. 
The density often obscures the underlying duct pattern. (Tucker and Ng 2001). 
2.4.2 Laszlo Tabar classification 
Laszlo Tabar classification is slightly different from Wolfe as presence of additional 
pattern and more detail description of each pattern. 
Pattern I: concave contour from Cooper's ligaments with evenly scattered 1-2mm 
nodular densities and oval-shaped/circular lucent areas. 
Pattern II: total fatty replacement without nodular densities. Has similar description 
with Nl pattern by Wolfe. 
Pattern III: normal parenchyma occupying <25% of breast volume in retro-areola 
region. It is similar to PI (Wolfe). 
Pattern IV: also called adenosis pattern. Described as scattered 3-7mm nodular 
densities (enlarged terminal ductal lobular unit), thick linear densities (periductal 
elastic tissue proliferation with fibrosis). This type of parenchyma pattern is 
genetically determined and does not change with increasing age. It is similar to P2 
(Wolfe). 
Pattern V: uniformly dense parenchyma with smooth contour (extensive fibrosis). It 
is similar to DY (Wolfe) (Dahnert 1996). 
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2.4.3 BIRADS classification 
BIRADS method classifies breast parenchyma into four categories:-
(I) Fatty 
(II) Scattered fibro-glandular densities 
(III) Heterogeneously dense 
(IV) Extremely dense 
Figure 2-5 Fatty breast 
Adapted fi·om Internet (Interactive Mammography Analysis Web Tutorial) 
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Figure 2-6 Scattered fibro glandular density 
Adapted from Internet (Interactive Mammography Analysis Web Tutorial) 
Figure 2-7 Heterogeneously dense 
Adapted from Internet (Interactive Mammography Analysis Web Tutorial) 
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Figure 2-8 Extremely dense 
Adapted from Internet (Interactive Mammography Analysis Web Tutorial) 
2.4.4 Boyd classification 
Semi quantitative assessment by Boyd et al. classified breast parenchyma into six 
categories:-
(a) Density= 0% 
(b) Density = >0% to < 1 0% of the area of breast 
(c) Density= I 0% to <25% 
(d) Density = 25% to <50% 
(e) Density = 50% to <75% 
(f) Density = >75% 
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2.4.5 Computer-aided quantitative assessment 
For computer-aided quantitative assessment, the films were digitized using 
Dicomed digital camera at 267dots/inch. These data is saved as TIFF files. The 
analysis of the digitized films was performed on a Power Macintosh 6100/66 
computer using the NIH Image program. The region of interest is then manually 
outlined and the region of interest is interactively threshold by using the Density Slice 
Tool. This is the best method to quantify the breast density (Chow, Venson et al. 
2000). 
2.5 Imaging of breast 
2.5.1 Mammography 
Mammography has been proved to be the single most important breast 
imaging technique, both for symptomatic or asymptomatic women (Tucker and Ng 
2001 ). This examination is performed as screening in asymptomatic women. There 
are few criteria needed for patient to be subjected for mammography screening. The 
criteria for screening according to Malaysian Guideline for screening mammography 
include high risk women that is women with past history of breast and or ovarian 
cancer, family history of breast cancer in one or more first or second degree relatives 
before the age of 50 years and history of atypia on previous biopsy before the age of 
40 years, at the discretion of doctors and the wish of patients. In these situations, 
mammography should be done annually for women age 40-49 years and annually or 
biennially for women age 50-75 years old. It is also performed in patient before 
23 
starting on Hormone Replacement Therapy (HRT) as a baseline investigation and to 
exclude underlying malignancy or lesion (Malaysia 2002). 
Guidelines produced by American College of Radiology, American Medical 
Association, National Cancer Institute are as below:-
a) Breast self-examination to begin at age 20. 
b) Breast examination by physician every 3 years between 20-40 years, in yearly 
intervals after age 40. 
c) Baseline mammogram between 35-40 years of age; follow-up screening based 
upon parenchyma pattern and family history. 
d) Initial screening at 30 years if the patient has first degree relative with breast cancer 
in pre menopausal years; follow-up screening upon parenchyma pattern. 
e) Mammography at yearly interval after age of 40. 
f) All women who have had prior breast cancer require annual follow-up. 
Diagnostic mammography is performed on women with breast symptoms such 
as mass, pain, nipple discharge, thickening, skin or nipple retraction and nipple 
eczema. Another indications include prior to breast surgery, follow up for breast 
cancer patients and work up for patients with metastases from an unknown primary 
tumour (G.Grainger and Allison 1999). 
Standard mammography is done in two views; cranio-caudal (CC) and 
mediolateral oblique (MLO) views. Additional views will be taken depending on 
indications. Magnified view done to further characterized lesions such as micro 
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